Arterial Network Launches Korea-Focused Medical Export Bootcamp: Customized Strategies for Global Market Entry
The product has secured a leading position in the domestic market and has initiated overseas sales; however, its share of the mainstream international market is growing slowly. How can we expand its prospects in overseas markets?
Having participated in overseas study tours and gained some understanding of international markets, one still needs to independently explore how to select target destinations, assess product application potential, and navigate regulatory approval and distribution channels. Where should one begin?
Overseas business development is another effective pathway for global expansion, but how can one identify suitable overseas partners?
Consider introducing new overseas technologies or incorporating emerging overseas medical solutions.Enhancing Business Diversification and New Competitive Advantages, how to search for high-potential overseas innovative technologies or products to accelerate internationalization?
In 2024, VCBeat will launch its Global Expansion Immersion Program, offering an immersive overseas study tour combined with on-the-ground consulting services for healthcare companies with innovative medical products seeking to expand into developed markets. The inaugural destination is South Korea—a regulated, high-margin, and undervalued blue-ocean market. As one of the largest export destinations for Chinese pharmaceutical products, South Korea presents a highly attractive market opportunity.
An Effective Gateway to Mainstream Healthcare Markets in Japan, Europe, and the United States
—— Clinical medical data and regulatory mechanisms have gained high international recognition, enabling the accumulation of mature market operational experience
As of 2022, Seoul had ranked among the top global cities for clinical trials for three consecutive years.First; South Korea ranks in terms of market share in the industry-led clinical trial market5.
South Korea’s regulatory level for domestically produced and imported drugs and vaccines reached the WHO’s highest level of medical product regulation in 2022.ML4(Maturity Level 4)
Innovative technologies offer ample room for sales pricing and profit margins.
——World-leading medical facilities and services, open to innovation, with extensive health insurance coverage and high reimbursement rates
Three South Korean (Seoul) hospitals are among the top 40 in the 2024 World’s Best Hospitals,Highest Volume in the Asian Market
The South Korean government’s national health insurance covers nearly all residents, with an average reimbursement rate for medical products of80%, with residents bearing 20% of the cost
There is vast potential for cooperation in the healthcare sector between China and South Korea.
—The two countries will strengthen medical cooperation, as both have strong demand for overseas products and share cultural and geographical proximity.
South Korea's healthcare expenditure as a percentage of GDP is nearly that of China's.1.5x(2020)
The average annual growth rate of the South Korean medical device market over the past five years has exceeded8%, Chinese medical devices show an overall upward trend in their import share
To gain a comprehensive understanding of the global expansion needs of enterprises, VCBeat is launching a specialized survey. We sincerely invite healthcare companies to participate, enabling us to deeply customize internationalization strategies and match corresponding resources, thereby helping your company rapidly establish a presence in South Korea, Europe, and the United States.
